These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18692133)

  • 1. Emtricitabine: Inhibitor and substrate of multidrug resistance associated protein.
    Bousquet L; Pruvost A; Didier N; Farinotti R; Mabondzo A
    Eur J Pharm Sci; 2008 Nov; 35(4):247-56. PubMed ID: 18692133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes.
    Janneh O; Jones E; Chandler B; Owen A; Khoo SH
    J Antimicrob Chemother; 2007 Nov; 60(5):987-93. PubMed ID: 17890284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of tenofovir and emtricitabine plus efavirenz: in vitro modulation of ABC transporter and intracellular drug accumulation.
    Bousquet L; Pruvost A; Guyot AC; Farinotti R; Mabondzo A
    Antimicrob Agents Chemother; 2009 Mar; 53(3):896-902. PubMed ID: 19075072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages.
    Jorajuria S; Dereuddre-Bosquet N; Becher F; Martin S; Porcheray F; Garrigues A; Mabondzo A; Benech H; Grassi J; Orlowski S; Dormont D; Clayette P
    Antivir Ther; 2004 Aug; 9(4):519-28. PubMed ID: 15456083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance-associated protein-1 functional activity in Calu-3 cells.
    Hamilton KO; Topp E; Makagiansar I; Siahaan T; Yazdanian M; Audus KL
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1199-205. PubMed ID: 11504821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy.
    Turriziani O; Gianotti N; Falasca F; Boni A; Vestri AR; Zoccoli A; Lazzarin A; Antonelli G
    J Med Virol; 2008 May; 80(5):766-71. PubMed ID: 18360888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of protease inhibitor-containing regimens on lymphocyte multidrug resistance transporter expression.
    Ford J; Meaden ER; Hoggard PG; Dalton M; Newton P; Williams I; Khoo SH; Back DJ
    J Antimicrob Chemother; 2003 Sep; 52(3):354-8. PubMed ID: 12917239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
    Calatozzolo C; Gelati M; Ciusani E; Sciacca FL; Pollo B; Cajola L; Marras C; Silvani A; Vitellaro-Zuccarello L; Croci D; Boiardi A; Salmaggi A
    J Neurooncol; 2005 Sep; 74(2):113-21. PubMed ID: 16193381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of P-glycoprotein and multidrug resistance proteins in rat kidney and intestinal cell lines.
    van de Water FM; Boleij JM; Peters JG; Russel FG; Masereeuw R
    Eur J Pharm Sci; 2007 Jan; 30(1):36-44. PubMed ID: 17088052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of noninferiority, safety, and tolerability of lopinavir/ritonavir and raltegravir compared with lopinavir/ritonavir and tenofovir/ emtricitabine in antiretroviral-naïve subjects: the progress study, 48-week results.
    Reynes J; Lawal A; Pulido F; Soto-Malave R; Gathe J; Tian M; Fredrick LM; Podsadecki TJ; Nilius AM
    HIV Clin Trials; 2011; 12(5):255-67. PubMed ID: 22180523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients.
    Hill A; Sawyer W
    HIV Med; 2009 Oct; 10(9):527-35. PubMed ID: 19785663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
    Marcelin AG; Charpentier C; Wirden M; Landman R; Valantin MA; Simon A; Katlama C; Yeni P; Descamps D; Aubron-Olivier C; Calvez V
    J Antimicrob Chemother; 2012 Jun; 67(6):1475-8. PubMed ID: 22371439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1.
    Sun M; Xu X; Lu Q; Pan Q; Hu X
    Cancer Lett; 2007 Feb; 246(1-2):300-7. PubMed ID: 16621244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line.
    Zastre JA; Chan GN; Ronaldson PT; Ramaswamy M; Couraud PO; Romero IA; Weksler B; Bendayan M; Bendayan R
    J Neurosci Res; 2009 Mar; 87(4):1023-36. PubMed ID: 18855943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines.
    Declèves X; Fajac A; Lehmann-Che J; Tardy M; Mercier C; Hurbain I; Laplanche JL; Bernaudin JF; Scherrmann JM
    Int J Cancer; 2002 Mar; 98(2):173-80. PubMed ID: 11857404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir.
    Janneh O; Anwar T; Jungbauer C; Kopp S; Khoo SH; Back DJ; Chiba P
    Antivir Ther; 2009; 14(7):965-74. PubMed ID: 19918100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP.
    Janneh O; Owen A; Chandler B; Hartkoorn RC; Hart CA; Bray PG; Ward SA; Back DJ; Khoo SH
    AIDS; 2005 Dec; 19(18):2097-102. PubMed ID: 16284458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract.
    Zimmermann C; Gutmann H; Hruz P; Gutzwiller JP; Beglinger C; Drewe J
    Drug Metab Dispos; 2005 Feb; 33(2):219-24. PubMed ID: 15523049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional expression of the multidrug resistance protein 1 in microglia.
    Dallas S; Zhu X; Baruchel S; Schlichter L; Bendayan R
    J Pharmacol Exp Ther; 2003 Oct; 307(1):282-90. PubMed ID: 12893836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy.
    Luna-Tortós C; Fedrowitz M; Löscher W
    Neuropharmacology; 2010 Jun; 58(7):1019-32. PubMed ID: 20080116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.